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2Abstract
Pericytes play important roles in vascular control and may form an important part of
the blood brain barrier. Here we introduce a simple method for fluorescently labelling
pericytes to enable further studies in live or fixed tissue of rats and mice. Following
intraperitoneal injection, the fluorescent tracer Fluorogold was rapidly taken up into
vascular endothelial cells, and within 3 hours in the central nervous system appeared
within small perivascular cells with a morphology consistent with pericytes. These
Fluorogold labelled cells were pericytes since they displayed immunoreactivity for
platelet derived growth factor receptor beta and were closely associated with
isolectin B4 binding to endothelial cells. Pericytes in skeletal muscle were also
labelled with this method, but not those within the heart, lungs or kidney. This simple
method could therefore be applied for labelling pericytes in a wide variety of studies,
including live cell imaging or immunohistochemistry.
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Introduction
Pericytes are perivascular cells found in close association with vascular endothelial
cells of small diameter vessels and capillaries. Within the CNS, pericytes play an
important role in angiogenesis, vascular stability, control of capillary blood flow and
macrophage activity (Rucker et al., 2000). Through either the use of transgenic mice
lacking pericytes, or in mice where the maturation of pericytes is inhibited, they have
been shown to be involved in the development of diabetic retinopathy (Enge et al.,
2002), neonatal intracranial haemorrhage (Li et al., 2011), some forms of
neurodegeneration (Bell et al., 2010) and in the development of the glial scar
following spinal cord injury (Goritz et al., 2011). There are currently many markers for
pericytes including: NG2 (Ozerdem et al., 2001), α-smooth muscle actin (Verbeek et 
al., 1994), CD13 (Kunz et al., 1994), and platelet derived growth factor beta
(PDGFRβ, (Lindahl et al., 1997; Winkler et al., 2010)). Unfortunately, none of these 
markers appear to be universal pericyte markers, rather they pick out pericytes in a
particular stage of maturation or they may be effective in a particular technique or
tissue (Armulik et al., 2011).
One approach used to circumvent issues labelling pericytes is to use genetically
altered animals which express marker proteins, but this relies on breeding and
maintenance of specific lines. An alternative approach that could be applied to all
mice, and indeed rats, would therefore be beneficial in promoting the study of
pericytes in physiological conditions and disease models. Progress towards this
aim, at least in the CNS, was made when cells with the morphology of pericytes
were labelled following intracerebroventricular injection of fluorescently conjugated
dextrans (Sarkar and Schmued, 2012). However, the use of intracerebroventricular
injection means a surgical step is required with related expense, time and welfare
requirements. Achieving similar pericyte labelling without surgery would therefore
represent an advance.
A potential candidate for labelling pericytes is the commonly used neuronal tracer
Fluorogold (FG) (Schmued and Fallon, 1986). FG is unable to cross the blood brain
barrier but when delivered peripherally via an intravascular or subcutaneous route
results in the labelling of discrete groups of neurones within the CNS, which send
axons out into the periphery (Ambalavanar and Morris, 1989). However, during our
3previous studies (e.g.(Edwards et al., 2013; Milligan et al., 2006)) we noticed that FG
injections result in labelling of cells other than neurones.
Here we identify that a single intraperitoneal injection of FG fluorescently labels
pericytes throughout the CNS and in skeletal muscle, rendering them visible for
further studies. This technique may therefore offer a simple method for labelling
pericytes without the need for surgery or the maintenance of transgenic animals.
Materials and Methods
All procedures were carried out in accordance with the UK Animals Scientific
Procedures Act 1986.
Animals
C57/BL6 mice (6 – 8 weeks, n = 12) were injected i.p. with FG (0.05 ml 1% in water,
25 mg/ kg, Fluorochrome, CO, USA). At 1, 3, 24 and 48 hours post- injection (n = 3
per group), animals were terminally anaesthetised with sodium pentobarbitone (60
mg / kg i.p.) and transcardially perfused with 200 ml of 4% paraformaldehyde. The
CNS, heart, lungs, kidneys and skeletal muscle were removed and post fixed for 24
hours in the same fixative. Tissue samples were then sectioned at 50 µm using a
vibratome (Leica VT1000M, UK). For all experiments n refers to the number of
animals used.
Adult male Wistar rats (250 g, n =3) were injected i.p with FG (0.1ml 1% in water, 5
mg / kg, Fluorochrome, CO , USA). 24 hours post injection animals were terminally
anaesthetised with sodium pentobarbitone and transcardially perfused with 500 ml of
4% paraformaldehyde. 9 day old, male wistar rats were also injected i.p. with FG
(0.1ml 1% in water, 50 mg / kg, n = 3). 24 hours post injection animals were
terminally anaesthetised using 60 mg / kg sodium pentobarbitone i.p. and then
transcardially perfused with ice cold aerated (95% O2, 5% CO2) sucrose artificial
cerebrospinal fluid containing (in mM): 217 sucrose, 26 NaCHO3, 3 KCl, 2 MgSO4,
2.5 NaH2PO4, 2 CaCl2, and 10 glucose. The brain was then removed and sliced at
200 µm using a vibrating microtome (Leica, VT1200S). Slices were then kept in
aerated artificial cerebrospinal fluid containing (in mM): 124 NaCl, 26 NaHCO3, 3
KCl, 2 MgSO4, 2.5 NaH2PO4, 2 CaCl2, and 10 glucose. Slices were then viewed
using an upright Olympus BX50WI microscope equipped for epifluorescence and
images captured using Q Capture pro6 (Scientifica, UK).
Immunohistochemistry
Tissue sections were blocked in donkey serum (10 % in PBS) containing 3 % triton
X-100 (PBS-T) for 1 hour at room temperature. All primary antibody incubations were
performed overnight at 4 ºC in 3 % PBS-T containing 5 % donkey serum and
secondary antibody incubations were performed at room temperature in PBS for 1-3
hours (Invitrogen Alexafluor secondaries) or 4 hours (Jackson Immunoresearch
biotinylated secondaries). Pericytes were identified by incubating tissue sections with
goat antibodies against PDGFRβ (1:500; R&D Systems, UK (Winkler et al., 2010)) 
and visualised using donkey anti goat Alexafluor555 (1:1000; Invitrogen, UK) or with
rat anti CD140b (1:250; eBioscience, INC) which was detected by biotinylated
secondary antibody (donkey anti rat; Jackson Immunoresearch, PA USA) and then
with Streptavidin Alexa488 (1:1000; Invitrogen, UK). To distinguish endothelial cells,
sections were labelled with biotinylated isolectin B4 (IB4) from Griffonia simplicifolia
(1:1000; Invitrogen) and detected using Strepavidin Alexa488 (1:1000;
4Invitrogen).Sections were washed three times in PBS and mounted onto slides using
Vectashield mounting medium (Vector Labs Ltd, UK) and viewed using a Nikon E600
epifluorescent microscope and Acquis image capture system (Synoptics, UK) or an
Upright Zeiss LSM510 confocal microscope.
Results
Optimal time for Fluorogold labelling
FG is used to retrogradely label neurons and is given as an injection 3 - 12 days
before perfusion (Anderson and Edwards, 1994; Milligan et al., 2006; Schmued and
Fallon, 1986). Here we explored whether a shorter time period would be sufficient to
label cells associated with blood vessels. Mice were injected i.p. with FG 1, 3, 24 or
48 hours prior to perfusion (n = 3 for each time point). Samples from throughout the
CNS showed that, after a period of 1 hour, there was dispersed labelling of tissue
with FG, which appeared to be associated with blood vessels (an example of a
putative FG labelled pericyte is shown in Fig. 1A). However, between 3 hours and 24
hours (Fig. 1B and 1C) distinct cells labelled with punctate, intracellular FG were
visible on blood vessels. The number and intensity of such FG labelled cells however
decreased 48 hours post injection (Fig. 1D). The FG labelling at 3 – 24 hours was
concentrated in the cell bodies with the morphology of pericytes, which were oval to
oblong in shape, although processes associated with these cells followed the
contours of the adjacent blood vessels. The method can extend also to rats since i.p.
FG labelled cells with the morphology of pericytes in CNS of adult (n=3) and juvenile
(n=3) rats (Fig. 1E-H). In addition, FG can be retained and imaged in these
perivascular cells in living CNS slices (n=3, Fig. 1G,H).
Fluorogold labelling co-localises with PDGFRβ in all investigated regions of 
the CNS
We used immunoreactivity (IR) for PDGRFβ as a marker for pericytes to confirm 
whether i.p. FG labelled these cells. In all experiments in which mice were injected
with FG 3 hours and 24 hours prior to perfusion we found FG positive cells that were
also PDGFRβ immunoreactive. These FG positive PDGFRβ immunoreactive cells 
were observed in all regions of the CNS that were investigated (olfactory bulbs,
hippocampus [Fig. 2A-A3], prefrontal cortex, hypothalamus [Fig. 2B-B3], area
postrema, medulla oblongata, and spinal cord, n = 6). To further confirm that this FG
labelling was present in pericytes, FG labelled cells were also probed for dual
labelling with an antibody raised against a different portion of PDGFRβ (CD140b, n = 
6). Again co-localisation of FG labelled pericytes and CD140b immunoreactivity was
observed throughout the CNS. To demonstrate the close association between the
FG labelled cells and the vasculature, the endothelial lining of the vessels was
labelled with IB4 (n=6). The FG labelled cells were always observed on the
abluminal surface of blood vessels.
Fluorogold labelling in various tissues and organs differs to that seen in the
CNS
As 3 hours post i.p. injection of FG is sufficient to label CNS pericytes we determined
whether this technique also labelled pericytes in other tissues and organs of the
mouse. Within skeletal muscle FG injection labelled small cells in close association
with the vasculature, which were also immunoreactive for PDGFRβ (n= 6, Fig. 2C-
C3). Within the heart FG strongly labelled the myocardium, and was totally absent
from the PDGFRβ-IR cells that were in close association to IB4 positive endothelial 
5cells (n = 6, Fig. 2D-D3). In the kidney strong FG labelling was observed exclusively
in glomeruli, whereas PDGFRβ immunoreactivity was observed in mesangial cells 
around and supporting the FG labelled glomerular capillaries. Endothelial cells within
the glomeruli and in the surrounding basement membrane were characterised with
IB4 (n = 6, Fig. 2E-E3).
Discussion
Here we report a novel method for labelling pericytes in rats and mice in vivo using
i.p. injection of FG. Although conventionally used as a neuronal tracer, FG is not
taken up by neuronal cells alone. Indeed, injection of FG into the dorsal columns of
rats resulted in the labelling of small cells surrounding the injection site, presumed to
be glial cells of the glial scar (Dado and Giesler, 1990). Further, ‘perivascular cells’
have been reported to be labelled with FG following injection into the corpus
callosum (Pennell and Streit, 1998) or the facial nucleus (Streit and Graeber, 1993).
IP administration of FG results in labelling of CNS pericytes within 3 hours, with a
punctate intracellular pattern suggesting it is localised to lysosomes as it is in
neurones (Persson and Havton, 2009). FG labelling of pericytes can still be
observed up to 48 hours post i.p. injection, although at a diminished level to that
observed at 3 or 24 hours. At 3 and 24 hours post i.p. injection, FG labelled pericytes
are clearly distinguishable from vascular endothelial cells within the CNS and
skeletal muscle. Within the heart, lungs, and kidney, FG labelling at the time points
investigated here no longer appears to be associated with perivascular structures. It
is unclear why a difference in the labelling of pericytes within different tissues was
observed. One possibility may be due to local differences in the pericyte populations
e.g. brain pericytes have a strong phagocytic ability, which may account for their
concentrating FG from the vasculature (Kristensson and Olsson, 1973). Another
option is that not all endothelial cells may be able to accumulate or transcytose the
FG since endothelial cells are well known to exhibit organ-specific phenotypes (Aird,
2007).
As FG does not permeate the blood brain barrier, it is interesting that pericytes are
able to accumulate the tracer at all. At the earlier time points we investigated, there
was clear labelling of the endothelial lining of blood vessels, which diminished over
time – co-incident with an increase in the intensity of the labelling of pericytes. In
transgenic mice with reduced numbers of brain pericytes, circulating tracers seem to
endocytose through the endothelial layer into neurons (Armulik et al., 2010). It
appears that the presence of pericytes slows the process of transcytosis across the
endothelial lining of microvessels. 2 hours after IV injection of horseradish
peroxidase (HRP), there appears to be a greater accumulation of HRP within the
endothelial cells of mutant mice with reduced pericyte numbers than their wild type
littermates. An alternative hypothesis may be that, when present, pericytes intercept
the HRP and play a role in its degradation, which would be consistent with the
apparent shift in FG labelling from endothelial cells into pericytes at the 3 hour time
point used here.
This method for labelling pericytes in vivo may prove to be a powerful tool to further
reveal the important roles that these cells play in the central nervous system and
musculature. This approach could easily be adapted to allow for further intravital
imaging of pericytes, or even to allow for simple cell selection in in vitro
electrophysiological studies – providing a distinct advantage over the currently used
pericyte markers.
6References
Aird, W. C., 2007. Phenotypic heterogeneity of the endothelium: II. Representative
vascular beds. Circ Res. 100, 174-90.
Ambalavanar, R., Morris, R., 1989. Fluoro-Gold injected either subcutaneously or
intravascularly results in extensive retrograde labelling of CNS neurones
having axons terminating outside the blood-brain barrier. Brain Res. 505, 171-
5.
Anderson, C. R., Edwards, S. L., 1994. Intraperitoneal injections of Fluorogold
reliably labels all sympathetic preganglionic neurons in the rat. J Neurosci
Methods. 53, 137-41.
Armulik, A., et al., 2011. Pericytes: developmental, physiological, and pathological
perspectives, problems, and promises. Dev Cell. 21, 193-215.
Armulik, A., et al., 2010. Pericytes regulate the blood-brain barrier. Nature. 468, 557-
61.
Bell, R. D., et al., 2010. Pericytes control key neurovascular functions and neuronal
phenotype in the adult brain and during brain aging. Neuron. 68, 409-27.
Dado, R. J., Giesler, G. J., Jr., 1990. Afferent input to nucleus submedius in rats:
retrograde labeling of neurons in the spinal cord and caudal medulla. J
Neurosci. 10, 2672-86.
Edwards, I. J., et al., 2013. Na+/K+ ATPase α1 and α3 isoforms are differentially 
expressed in α- and γ- motoneurons. Journal of Neuroscience. In Press. 
Enge, M., et al., 2002. Endothelium-specific platelet-derived growth factor-B ablation
mimics diabetic retinopathy. EMBO J. 21, 4307-16.
Goritz, C., et al., 2011. A pericyte origin of spinal cord scar tissue. Science. 333,
238-42.
Kristensson, K., Olsson, Y., 1973. Accumulation of protein tracers in pericytes of the
central nervous system following systemic injection in immature mice. Acta
Neurol Scand. 49, 189-94.
Kunz, J., et al., 1994. The 140-kDa protein of blood-brain barrier-associated
pericytes is identical to aminopeptidase N. J Neurochem. 62, 2375-86.
Li, F., et al., 2011. Endothelial Smad4 maintains cerebrovascular integrity by
activating N-cadherin through cooperation with Notch. Dev Cell. 20, 291-302.
Lindahl, P., et al., 1997. Pericyte loss and microaneurysm formation in PDGF-B-
deficient mice. Science. 277, 242-5.
Milligan, C. J., et al., 2006. HCN1 ion channel immunoreactivity in spinal cord and
medulla oblongata. Brain Res. 1081, 79-91.
Ozerdem, U., et al., 2001. NG2 proteoglycan is expressed exclusively by mural cells
during vascular morphogenesis. Dev Dyn. 222, 218-27.
Pennell, N. A., Streit, W. J., 1998. Tracing of fluoro-gold prelabeled microglia injected
into the adult rat brain. Glia. 23, 84-8.
7Persson, S., Havton, L. A., 2009. Retrogradely transported fluorogold accumulates in
lysosomes of neurons and is detectable ultrastructurally using post-
embedding immuno-gold methods. J Neurosci Methods. 184, 42-7.
Rucker, H. K., et al., 2000. Cellular mechanisms of CNS pericytes. Brain Res Bull.
51, 363-9.
Sarkar, S., Schmued, L., 2012. In vivo administration of fluorescent dextrans for the
specific and sensitive localization of brain vascular pericytes and their
characterization in normal and neurotoxin exposed brains. Neurotoxicology.
33, 436-43.
Schmued, L. C., Fallon, J. H., 1986. Fluoro-Gold: a new fluorescent retrograde
axonal tracer with numerous unique properties. Brain Res. 377, 147-54.
Streit, W. J., Graeber, M. B., 1993. Heterogeneity of microglial and perivascular cell
populations: insights gained from the facial nucleus paradigm. Glia. 7, 68-74.
Verbeek, M. M., et al., 1994. Induction of alpha-smooth muscle actin expression in
cultured human brain pericytes by transforming growth factor-beta 1. Am J
Pathol. 144, 372-82.
Winkler, E. A., et al., 2010. Pericyte-specific expression of PDGF beta receptor in
mouse models with normal and deficient PDGF beta receptor signaling. Mol
Neurodegener. 5, 32.
8Figure Legends
Figure 1. Optimal time for labelling CNS pericytes with Fluorogold (FG)
Time course for FG labelling at 1 (A), 3 (B), 24 (C), and 48 hours (D) after i.p.
administration of FG. After 1 hour FG was mainly visible in the endothelial lining of
blood vessels, becoming concentrated within pericytes over 3-24 hours (labelled
pericytes marked with arrows), whilst the endothelial associated labelling had
decreased. Neuronal labelling (N) becomes apparent at 48 hours. FG also labels
CNS pericytes in the rat, cortex (E) and thalamus (F). FG labelled pericytes are also
visible in live slices of rat brain (G) and DIC shows that they are confined to blood
vessels and are not associated with neighbouring healthy neurones (H).
9Figure 2. Fluorogold labels pericytes in the CNS, but not other organs
FG labelled PDGFRβ IR cells in the hippocampus (HPX, A-A3) and hypothalamus 
(HYP, B-B3) of the CNS and skeletal muscle (C-C3). FG did not label pericytes
within cardiac (D-D3) and renal (E-E3) tissue.
